In patients with NAFLD and T2DM, fasting ghrelin concentrations were lower and fasting GLP-1 concentrations were higher, compared to patients without T2DM (Supplementary Table 1). This evidence concerns the gene GHRL and metabolic dysfunction-associated steatotic liver disease.